Healthy volunteers help test new drug MRX1
NCT ID NCT06854783
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 29 times
Summary
This study tested an investigational drug called MRX1 in 20 healthy adults aged 18 to 55. The goal was to see how the body absorbs and processes the drug, check for side effects, and find out if food changes how the drug works. This is an early-phase study with no direct treatment benefit for participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.